Kent Iverson has more than 30 years of experience in biopharmaceutical analytical development, process development, and manufacturing. He has served as the CMC leader for Acumen since 2013. Prior to becoming a biologics CMC consultant in 2001, Mr. Iverson was vice president of process development at Corixa Corporation and vice president of manufacturing at Coulter Pharmaceutical, Inc., while supporting the commercialization of Bexxar™. Earlier in his career he participated in the development of Genentech’s Protropin™ and Activase™, and Immunex’s Leukine™ and Enbrel™. As an independent consultant Mr. Iverson has supported CMC development from preclinical stage to post-registration stage for clients in the North America, the EU, and the Asia/Pacific regions. He holds a BS in fermentation science from the University of California at Davis.